What is the recommended starting dose of levothyroxine (T4) for adults with hypothyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levothyroxine Starting Dose for Adults with Hypothyroidism

The recommended starting dose of levothyroxine for adults with hypothyroidism is 1.6 mcg/kg/day for patients under 70 years without cardiac disease, while older patients or those with cardiac disease should start at a lower dose of 25-50 mcg/day. 1, 2

Dosing Based on Patient Characteristics

Standard Adult Dosing

  • Full replacement dose is 1.6 mcg/kg/day for adults diagnosed with hypothyroidism who are under 70 years without cardiac disease 1, 2
  • Titrate dosage by 12.5 to 25 mcg increments every 4-6 weeks until the patient is euthyroid 2
  • Most patients require between 100-150 mcg/day 3

Special Populations

  • For patients over 70 years or with cardiac disease/risk for atrial fibrillation: start with 25-50 mcg/day 1, 2
  • For elderly patients: Consider a lower dose of approximately 1.09 μg/kg or 1.35 μg/kg based on ideal body weight (about one-third lower than standard adult dosing) 4
  • Titrate more slowly (every 6-8 weeks) in elderly patients or those with cardiac disease 1, 2

Dosing Based on TSH Levels

Overt Hypothyroidism

  • For patients with overt hypothyroidism (elevated TSH and low free T4), replacement therapy is clearly indicated 1, 5
  • Higher pretreatment TSH levels correlate with higher ultimate levothyroxine requirements 3

Subclinical Hypothyroidism

  • For TSH >10 mIU/L with normal free T4: initiate levothyroxine therapy regardless of symptoms 1
  • For TSH between 4.5-10 mIU/L with normal free T4: treatment decisions should be individualized based on symptoms, presence of TPO antibodies, and other risk factors 1, 5

Monitoring and Dose Adjustment

  • Check TSH every 6-8 weeks while titrating the dose 1
  • Target TSH should be within the reference range (0.5-4.5 mIU/L) 1
  • Once stable, monitor TSH every 6-12 months 1
  • Free T4 can help interpret abnormal TSH levels during therapy 1

Common Pitfalls to Avoid

  • Overtreatment risks include iatrogenic hyperthyroidism, which increases risk for atrial fibrillation, osteoporosis, and fractures 1, 5
  • About 25% of patients on levothyroxine are unintentionally maintained on doses sufficient to fully suppress TSH 1
  • Undertreatment risks include persistent hypothyroid symptoms and adverse effects on cardiovascular function 1
  • Failure to recognize transient hypothyroidism may lead to unnecessary lifelong treatment 1
  • Adjusting doses too frequently before reaching steady state (should wait 4-6 weeks between adjustments) 1

Administration Considerations

  • Administer levothyroxine on an empty stomach, at least 30-60 minutes before food 2
  • Certain medications (iron, calcium) and foods can reduce levothyroxine absorption 2, 6
  • Dosages greater than 200 mcg/day are seldom required; inadequate response to >300 mcg/day may indicate poor compliance, malabsorption, or drug interactions 2

Special Clinical Scenarios

  • For women planning pregnancy: more aggressive normalization of TSH is warranted 1, 6
  • For patients with both adrenal insufficiency and hypothyroidism: steroids should always be started prior to thyroid hormone to avoid an adrenal crisis 1
  • For patients with thyroid cancer requiring TSH suppression: target TSH levels may be intentionally lower, requiring consultation with an endocrinologist 1

References

Guideline

Initial Treatment for Elevated TSH

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Levothyroxine Dosing in Older Adults: Recommendations Derived From The Baltimore Longitudinal Study of Aging.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2023

Research

Hypothyroidism: Diagnosis and Treatment.

American family physician, 2021

Related Questions

What is the appropriate treatment for a patient with mild hypothyroidism and lab results showing elevated TSH, low T4, and low FT4I?
What is the recommended treatment for an 11-year-old obese male with hypothyroidism, characterized by an elevated Thyroid-Stimulating Hormone (TSH) level and low Free Thyroxine (FT4) level?
How should the dose of Eltroxin (levothyroxine) be adjusted for a patient with rising TSH levels and suboptimal thyroid control?
What is the appropriate workup and treatment plan for a 32-year-old female with symptoms of hypothyroidism, a Thyroid-Stimulating Hormone (TSH) level of 0.639 and a Thyroxine (T4) level of 0.68?
What's the next step for a 34-year-old male with hypothyroidism taking 75 mcg of Levothyroxine (thyroxine) with a Thyroid-Stimulating Hormone (TSH) level of 0.021 and free T4 of 2.33 ng/dl after 8 weeks?
What are the key points to emphasize when counseling patients on Valcyclovir (valacyclovir) treatment?
What is the next step in management for a patient with a neurotoxic snake bite presenting with ptosis that does not improve with 1.5 mg of neostigmine (acetylcholinesterase inhibitor) and atropine (anticholinergic medication)?
What is the difference between type 1 and type 2 diabetes in terms of causes and management?
What are the management differences between Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS)?
What is the recommended duration and choice of anticoagulants, such as warfarin (Vitamin K antagonist) or direct oral anticoagulants (DOACs) like apixaban (Direct Oral Anticoagulant), for a patient with a left apical clot?
What is the dosing regimen for Rituximab (rituximab) as part of a desensitization protocol for a kidney transplant workup patient with positive Donor-Specific Antibodies (DSA)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.